OPERA LIFE

OPERA is seeking investment to advance its platform for collecting and managing organ transplantation data, from donor assessment and organ preservation to patient follow-up, with a foundation designed for future AI-powered analysis.

We address a key challenge in transplantation: clinical and preservation data are often fragmented across different systems, limiting their use in research and outcome analysis. OPERA aims to connect these data in a structured environment, creating a basis for future predictive tools.

Investment will support software development, integration with clinical systems and preservation devices, pilot studies, and the quality, data protection and regulatory activities needed for market entry. It will also help strengthen our technical and commercial capabilities.

Our development strategy starts with data collection and management, followed by the development and validation of advanced analytical capabilities. This phased approach allows us to address practical data needs while building the evidence required for future clinical decision support.

We welcome discussions with early-stage investors, healthcare-focused funds, business angels and strategic corporate partners. Beyond capital, we value expertise in digital health, clinical adoption and access to healthcare markets.

Our ambition is to make transplant data more useful throughout the clinical pathway and build a sustainable business through long-term relationships with transplant centres, research organisations and industry partners.